Pregnancy drug safety registry for people with HIV treatment
Part of Digestive system, Immune system & allergy, Infections clinical trials.
This trial is a pregnancy registry that collects information about birth outcomes when certain HIV medicines are taken during pregnancy. It helps detect any major birth defects so future pregnancies can be safer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a person who could become pregnant or was pregnant
- Your pregnancy included taking one of the medicines in the registry
- You can provide enough details to classify when during pregnancy the medicine was taken
- There is enough information to record whether the pregnancy is listed now or after the outcome is known
- You (or your healthcare team) can share contact details for follow-up
- The report comes with enough identifiers to allow the registry to reach back out
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study measures how HIV medicines move through your body during pregnancy by collecting blood samples after you take your regular treatment. It may help improve understanding of dosing and drug levels in pregnant people living with HIV.
This study tests how well two different pill combinations work together to prevent HIV and pregnancy. You'll take daily birth control pills and daily HIV prevention pills, and researchers will check your health regularly for about a year.
This registry study looks at people who are HIV-negative but at high risk of getting HIV, to better understand risk and care needs. If you qualify, you may be asked to share health and behavior information to help guide future prevention efforts.
This study tests a new injectable drug (VH4011499) for safety and how the body processes it. It's for healthy adults without HIV, and participants will get either the study drug or a placebo (an inactive shot).
This trial tests whether an experimental HIV vaccine, given with an adjuvant to boost the immune response, is safe and produces an immune response in infants who were exposed to HIV in the womb but are not infected. The study aims to help protect these vulnerable infants.
This is an observational study that collects real-world information about pregnancy outcomes when relugolix-containing therapy is taken during pregnancy. It aims to better understand safety for both the parent during pregnancy and the child after birth.
Hear when a new HIV Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.